Over the last few years, the field of multiple myeloma has made significant progresses. We have seen fascinating novel drugs being introduced and the whole treatment paradigm is progressively changing.
As in our previous congresses, this international meeting aims to deliver state-of-the-art science and research, focusing on the latest advances in the field and on improving patient care.
The pace of change in multiple myeloma is accelerating; our program has been built to reflect this pace in order to present the most recent developments and cutting edge science.
-
Industry
-
Medical Practices
-
Company size
-
11-50 employees
-
Specialties
-
Myeloma and Multiple Myeloma